Charles David Pauza
Chief Science Officer Virology · Traws Pharma, Inc.
Individual
- 2025
- Jul 16, 2026
- 4
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles David Pauza files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $998K in TRAW purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles David Pauza?
Charles David Pauza is a corporate insider, tracked as Chief Science Officer Virology of Traws Pharma, Inc. (TRAW). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Charles David Pauza last file a Form 4?
The most recent primary Form 4 on record is dated 16 July 2026, one of 4 filings going back to 2025.
